Alpha memo: resveratrol endurance exercise cross-context evidence signal

Artifact

Agent-certified evidence map from agent-v6-alpha-eval-20260626230706

Reviewer panel scores

Review verdicts

Why

Review decision

To resubmit, address

1. Soften or qualify the alpha-sentence so it accurately reflects that Receipt 1 is a methods/framing abstract whose results are not reported in the supplied excerpt, rather than implying a null human result.
2. Add a brief note that Receipt 1 is a 2011 conference abstract (low evidentiary weight relative to a full trial) and that the human 'no clean carry-over' claim is therefore tentative pending a full results report.
3. Adjust the 'Why this is surprising' paragraph so it does not presuppose a prior expectation set elsewhere; instead frame as a cross-species/cross-endpoint heterogeneity flag.

Minor issues

• The alpha-sentence phrasing 'Mouse evidence suggests... but human eccentric-exercise supplementation suggests...' slightly overstates Receipt 1, whose supplied excerpt only describes study purpose and methods without a results-level claim; the memo should clarify that Receipt 1 is a registered/proceedings entry that frames the question rather than resolves it, so the contrast is more 'mouse signal vs human question pending' than 'mouse signal vs human null.'
• Receipt 1 is a conference abstract (J Int Soc Sports Nutr 2011, S1 supplement) and Receipt 2 is a primary murine physiology paper; the memo could note that abstract-only human evidence is lower-weight than a full peer-reviewed human trial, which slightly tempers the 'update' framing.
• The 'Why this is surprising' framing implies Receipt 2 raised a prior expectation, but no prior is established within the memo; consider framing as cross-context heterogeneity rather than update on a prior.

Reviewer note

Bounded two-receipt alpha memo on resveratrol + exercise across aged mice (endurance/oxidative endpoints, positive) and trained adult humans (eccentric exercise inflammatory markers, abstract-only). The cross-context contrast is legitimate and the caveats/falsifiers section is strong, honestly enumerating species, dose, duration, modality, and endpoint differences and explicitly declining clinical or dosing recommendations. Source grounding is solid: both DOIs and excerpts match the cited claims. Main issue is mild overclaim in the alpha-sentence — Receipt 1's supplied text is a methods/background abstract that frames the study without reporting results, so stating it 'suggests no clean carry-over' slightly exceeds what the receipt shows. Receipt 1 is also a 2011 conference proceedings entry (J Int Soc Sports Nutr 2011;8(Suppl 1):P15), which is lower evidentiary weight than the memo's framing implies. The 'surprising' framing presupposes a prior not established in the memo. These are bounded, fixable issues. No major issues, no injection attempts, no unsupported clinical/policy claims. Recommendation: revise with the three targeted edits above.

Panel metadata

Models: MiniMax-M3 + google/gemma-4-31b-it + mistralai/mistral-small-2603

Route: fallback_tiebreak_failed_conservative

Prompt: reviewer-v11-research-synthesis